Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

2002203 citationsJournal Article

Authors

Masato Sakon · Osaka City University

Hiroaki Nagano · Osaka University

Keizo Dono · Osaka University

Shoji Nakamori · Osaka University

Koji Umeshita · Osaka University

Akira Yamada · Osaka University

Sumio Kawata · Osaka University

Abstract

Simple combination therapy with subcutaneous interferon-alpha and intraarterial 5-fluorouracil therefore is a promising treatment modality for intractable HCC with Vp3.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Viral-associated cancers and disorders Liver Disease and Transplantation

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Cancer

Volume 94, Issue 2, pp. 435-442

DOI: 10.1002/cncr.10246

Field-Weighted Citation Impact: 5.30